4148.TW · ACBT
Taiwan · RS rating 41 · As of 2026-10-08
| Price | 31.95 TWD |
|---|---|
| 1-day change | -0.5% |
| RS rating (overall / 1M / 3M / 12M) | 41 / 55 / 77 / 25 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 36 / 9 / 53 |
| Industry group (rank) | Biotechnology & Medical Care (50) |
| EPS growth Q/Q | +1325.0% |
| Sales growth Q/Q | +86.6% |
| Distance from 52-week high | +26.7% |
| Market cap (USD) | $66.3M |